-
Kenya's economy faces climate change risks: World Bank
-
Gold, silver prices tumble as investors soothed by Trump Fed pick
-
US Senate votes on funding deal - but shutdown still imminent
-
Trump expects Iran to seek deal to avoid US strikes
-
NASA delays Moon mission over frigid weather
-
Fela Kuti: first African to get Grammys Lifetime Achievement Award
-
Cubans queue for fuel as Trump issues oil ultimatum
-
France rescues over 6,000 UK-bound Channel migrants in 2025
-
Analysts say Kevin Warsh a safe choice for US Fed chair
-
Fela Kuti to be first African to get Grammys Lifetime Achievement Award
-
Gold, silver prices tumble as investors soothed by Trump's Fed pick
-
Social media fuels surge in UK men seeking testosterone jabs
-
Trump nominates former US Fed official as next central bank chief
-
Chad, France eye economic cooperation as they reset strained ties
-
Artist chains up thrashing robot dog to expose AI fears
-
Dutch watchdog launches Roblox probe over 'risks to children'
-
Cuddly Olympics mascot facing life or death struggle in the wild
-
UK schoolgirl game character Amelia co-opted by far-right
-
Panama court annuls Hong Kong firm's canal port concession
-
Asian stocks hit by fresh tech fears as gold retreats from peak
-
Apple earnings soar as China iPhone sales surge
-
With Trump administration watching, Canada oil hub faces separatist bid
-
What are the key challenges awaiting the new US Fed chair?
-
Moscow records heaviest snowfall in over 200 years
-
Polar bears bulk up despite melting Norwegian Arctic: study
-
Waymo gears up to launch robotaxis in London this year
-
French IT group Capgemini under fire over ICE links
-
Czechs wind up black coal mining in green energy switch
-
EU eyes migration clampdown with push on deportations, visas
-
Northern Mozambique: massive gas potential in an insurgency zone
-
Gold demand hits record high on Trump policy doubts: industry
-
UK drugs giant AstraZeneca announces $15 bn investment in China
-
Ghana moves to rewrite mining laws for bigger share of gold revenues
-
Russia's sanctioned oil firm Lukoil to sell foreign assets to Carlyle
-
Gold soars towards $5,600 as Trump rattles sabre over Iran
-
Deutsche Bank logs record profits, as new probe casts shadow
-
Vietnam and EU upgrade ties as EU chief visits Hanoi
-
Hongkongers snap up silver as gold becomes 'too expensive'
-
Gold soars past $5,500 as Trump sabre rattles over Iran
-
Samsung logs best-ever profit on AI chip demand
-
China's ambassador warns Australia on buyback of key port
-
As US tensions churn, new generation of protest singers meet the moment
-
Venezuelans eye economic revival with hoped-for oil resurgence
-
Samsung Electronics posts record profit on AI demand
-
Formerra to Supply Foster Medical Compounds in Europe
-
French Senate adopts bill to return colonial-era art
-
Tesla profits tumble on lower EV sales, AI spending surge
-
Meta shares jump on strong earnings report
-
Anti-immigration protesters force climbdown in Sundance documentary
-
Springsteen releases fiery ode to Minneapolis shooting victims
Morocco starts construction of anti-Covid vaccine plant
Morocco on Thursday inaugurated construction of an anti-Covid vaccine manufacturing plant in partnership with Swedish firm Recipharm, the official news agency MAP reported.
The factory to be known as Sensyo Pharmatech will produce vaccines against coronavirus and other diseases, with production expected to reach 116 million units in 2024, MAP said.
It was launched in Benslimane, a region of Morocco's economic hub Casablanca during a ceremony attended by King Mohammed VI, it said.
The plant will need investments of between 400-500 million euros ($445 million-$557 million).
It is aimed at ensuring vaccine "self-sufficiency" for the North African kingdom, MAP said.
Its goal is to make, between 2022 and 2025, "active substances for more than 20 vaccines, three of which would be against coronavirus... to cover 70 percent of the kingdom's needs and more than 60 percent of needs across Africa", the agency said.
Morocco is already producing the Chinese anti-Covid Sinopharm vaccine, with more than three million doses being made per month.
By next month it plans on producing five million doses and more than 20 million by the end of the year.
Home to 36 million inhabitants, Morocco is hoping that its vaccination drive will help eradicate Covid-19. More than 23 million people have already received a second dose against coronavirus, according to the health ministry.
Authorities hope to vaccinate 80 percent of the population with either Sinopharm or Pfizer-BioNTech.
In July, Recipharm said it had signed a memorandum of understanding with Morocco and a consortium of the country's leading banks to build a factory to produce vaccines and biotherapeutics in the kingdom.
As part of the deal, it said in a statement at the time, $500 million would be invested into the project by the Moroccan government and consortium.
"The investment is primarily to supply the African continent and help it gain vaccine sovereignty and access to future biotherapeutics," it said.
Y.Uduike--CPN